Cue Biopharma Stock (NASDAQ:CUE), Quotes and News Summary

Q: What sector and industry does Cue Biopharma (CUE) operate in?

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cue Biopharma Stock (NASDAQ: CUE) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 258.391K
Day Range	- - -
52 Wk Range	1.470 - 5.120
Market Cap	$80.261M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	8.9%
Days to Cover	21.09

Recent News

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Avi Kapoor

Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying

The Dow Jones closed higher by close to 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cue Biopharma Inc

Sector

Health Care

Industry

Biotechnology

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and propri...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cue Biopharma (CUE) stock?

You can purchase shares of Cue Biopharma (NASDAQ: CUE) through any online brokerage.

View our list of the best stock brokerages.

Who are Cue Biopharma's (CUE) competitors?

Other companies in Cue Biopharma’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR) and Elicio Therapeutics (NASDAQ:ELTX).

What is the target price for Cue Biopharma (CUE) stock?

The latest price target for Cue Biopharma (NASDAQ: CUE) was reported by Stifel on Tuesday, April 9, 2024. The analyst firm set a price target for 8.00 expecting CUE to rise to within 12 months (a possible 384.85% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for Cue Biopharma (CUE)?

The stock price for Cue Biopharma (NASDAQ: CUE) is $1.65 last updated April 18, 2024 at 6:14 PM EDT.

Does Cue Biopharma (CUE) pay a dividend?

There are no upcoming dividends for Cue Biopharma.

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

Cue Biopharma’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Cue Biopharma (CUE) going to split?

There is no upcoming split for Cue Biopharma.

What sector and industry does Cue Biopharma (CUE) operate in?

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-